As the OP has mentioned, this is the Indian government's response to Novartis. Here is the background: 1. In April, India's Supreme Court denied Novartis' pate

As the OP has mentioned, this is the Indian government's response to Novartis. Here is the background: 1. In April, India's Supreme Court denied Novartis' patent application for its cancer drug Glivec. They reasoned that Novartis was "evergreening" the drug, and thus did not deserve a patent for a new drug - http://articles.economictimes.indiatimes.com/2013-04-02/news/38218279_1_glivec-patent-office-fresh-patent http://articles.economictimes.indiatimes.com/2013-04-02/news... 2. Novartis complained, naturally - http://www.novartis.com/newsroom/media-releases/en/2013/1689290.shtml http://www.novartis.com/newsroom/media-releases/en/2013/1689... [Edited: a couple of typos]